Mechanism-based modeling of complex biomedical systems.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Mechanism-based modeling of complex biomedical systems. / Mosekilde, Erik; Sosnovtseva, Olga; Holstein-Rathlou, N.-H.

In: Basic & Clinical Pharmacology & Toxicology, Vol. 96, No. 3, 2005, p. 212-24.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mosekilde, E, Sosnovtseva, O & Holstein-Rathlou, N-H 2005, 'Mechanism-based modeling of complex biomedical systems.', Basic & Clinical Pharmacology & Toxicology, vol. 96, no. 3, pp. 212-24. https://doi.org/10.1111/j.1742-7843.2005.pto960311.x

APA

Mosekilde, E., Sosnovtseva, O., & Holstein-Rathlou, N-H. (2005). Mechanism-based modeling of complex biomedical systems. Basic & Clinical Pharmacology & Toxicology, 96(3), 212-24. https://doi.org/10.1111/j.1742-7843.2005.pto960311.x

Vancouver

Mosekilde E, Sosnovtseva O, Holstein-Rathlou N-H. Mechanism-based modeling of complex biomedical systems. Basic & Clinical Pharmacology & Toxicology. 2005;96(3):212-24. https://doi.org/10.1111/j.1742-7843.2005.pto960311.x

Author

Mosekilde, Erik ; Sosnovtseva, Olga ; Holstein-Rathlou, N.-H. / Mechanism-based modeling of complex biomedical systems. In: Basic & Clinical Pharmacology & Toxicology. 2005 ; Vol. 96, No. 3. pp. 212-24.

Bibtex

@article{6e740410ab6011ddb5e9000ea68e967b,
title = "Mechanism-based modeling of complex biomedical systems.",
abstract = "Mechanism-based modeling is an approach in which the physiological, pathological and pharmacological processes of relevance to a given problem are represented as directly as possible. This approach allows us (i) to test whether assumed hypotheses are consistent with observed behaviour, (ii) to examine the sensitivity of a system to parameter variation, (iii) to learn about processes not directly amenable to experimentation, and (iv) to predict system behavior under conditions not previously experienced. The paper illustrates different aspects of the application of mechanism-based modeling through three different examples of relevance to the treatment of diabetes and hypertension: subcutaneous absorption of insulin, pulsatile insulin secretion in normal young persons, and synchronization of the pressure and flow regulation in neighbouring nephrons. The underlying ideas are that each regulatory mechanism represents the target for intervention and that the development of new and more effective drugs must be based on a deeper understanding of the biological processes.",
author = "Erik Mosekilde and Olga Sosnovtseva and N.-H. Holstein-Rathlou",
note = "Keywords: Blood Glucose; Diabetes Mellitus; Humans; Hypertension; Insulin; Models, Biological; Nephrons; Skin Absorption",
year = "2005",
doi = "10.1111/j.1742-7843.2005.pto960311.x",
language = "English",
volume = "96",
pages = "212--24",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Mechanism-based modeling of complex biomedical systems.

AU - Mosekilde, Erik

AU - Sosnovtseva, Olga

AU - Holstein-Rathlou, N.-H.

N1 - Keywords: Blood Glucose; Diabetes Mellitus; Humans; Hypertension; Insulin; Models, Biological; Nephrons; Skin Absorption

PY - 2005

Y1 - 2005

N2 - Mechanism-based modeling is an approach in which the physiological, pathological and pharmacological processes of relevance to a given problem are represented as directly as possible. This approach allows us (i) to test whether assumed hypotheses are consistent with observed behaviour, (ii) to examine the sensitivity of a system to parameter variation, (iii) to learn about processes not directly amenable to experimentation, and (iv) to predict system behavior under conditions not previously experienced. The paper illustrates different aspects of the application of mechanism-based modeling through three different examples of relevance to the treatment of diabetes and hypertension: subcutaneous absorption of insulin, pulsatile insulin secretion in normal young persons, and synchronization of the pressure and flow regulation in neighbouring nephrons. The underlying ideas are that each regulatory mechanism represents the target for intervention and that the development of new and more effective drugs must be based on a deeper understanding of the biological processes.

AB - Mechanism-based modeling is an approach in which the physiological, pathological and pharmacological processes of relevance to a given problem are represented as directly as possible. This approach allows us (i) to test whether assumed hypotheses are consistent with observed behaviour, (ii) to examine the sensitivity of a system to parameter variation, (iii) to learn about processes not directly amenable to experimentation, and (iv) to predict system behavior under conditions not previously experienced. The paper illustrates different aspects of the application of mechanism-based modeling through three different examples of relevance to the treatment of diabetes and hypertension: subcutaneous absorption of insulin, pulsatile insulin secretion in normal young persons, and synchronization of the pressure and flow regulation in neighbouring nephrons. The underlying ideas are that each regulatory mechanism represents the target for intervention and that the development of new and more effective drugs must be based on a deeper understanding of the biological processes.

U2 - 10.1111/j.1742-7843.2005.pto960311.x

DO - 10.1111/j.1742-7843.2005.pto960311.x

M3 - Journal article

C2 - 15733217

VL - 96

SP - 212

EP - 224

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 3

ER -

ID: 8420053